Measuring Uniformed Servicemembers' Fitness Scores on Creatine Loading and Exercise (MUSSCLE)

Measuring Uniformed Servicemembers' Fitness Scores on Creatine Loading and Exercise (MUSSCLE)

The purpose of this study is to compare the physical fitness performance-as measured by the Air Force Physical Fitness Test (PFT)-of subjects that, in conjunction with exercise, will take creatine supplementation over a four week period versus those that do not.

Study Overview

• Status: Terminated
• Conditions: Physical Fitness
• Intervention / Treatment: Dietary supplement: Rice Flour; Dietary supplement: Creatine Monohydrate

Detailed Description

The purpose of this study is to compare the physical fitness performance-as measured by the Air Force Physical Fitness Test (PFT)-of subjects that, in conjunction with exercise, will take creatine supplementation over a four week period versus those that do not. Based on the literature, there is evidence to support that creatine supplementation may increase available levels of muscle phosphocreatine (PCr), an important energy reservoir that is initially expended with intense muscular contraction and then regenerated during episodes of rest. While mechanistically plausible, the effects of creatine on the specific measures of the PFT (push-ups, sit-ups, 1.5 mile run, and abdominal circumference) have not been evaluated. The target population is Active Duty Air Force (ADAF) service members who perform perform the PFT. As such, this represents a population with occupational requirements to maintain their fitness at a designated level. If short-term creatine supplementation does help to improve PFT scores, trainers, commanders, and unit physicians may wish to consider recommending its use. While generally considered safe, additional data will also be collected to evaluate both the qualitative and quantitative side-effects of creatine supplementation over the study period. If the hypothesis is correct and creatine supplementation is shown to be both effective and safe, additional studies may be warranted to evaluate its impact on ADAF service members who have failed the PFT and/or are at risk of being separated from the AF for unsatisfactory fitness performance. In short, this study has the potential to dramatically affect the recommendations and practices of ADAF service members related to use of creatine supplementation.

• Study Type: Interventional
• Enrollment (Actual): 6
• Phase: Not Applicable

Contacts and Locations

Study Locations

• United States
  • California
    • Fairfield, California, United States, 94535
      • David Grant Medical Center

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 89 years (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• Male or Female
• Age ≥18
• Willing to exercise five days per week for four weeks, performing each component of the AF PFT at least once per week
• Willing to adhere to a prescribed supplementation regimen, including spaced dosing two times per day
• Able to meet all study follow-up and testing requirements as outlined in section 6.4 of this protocol

Exclusion Criteria:

• History of:
• Chronic kidney dysfunction
• Liver failure
• Rhabdomyolysis
• Compartment syndrome
• Current
• Pregnancy
• Musculoskeletal injury
• Fitness exemption from any component of the AF PFT (e.g. AF 469, "profile")
• Kidney injury
• Diabetes
• Hypertension, requiring medication
• Allergy to rice
• Admission to the hospital within the past 30 days
• Creatine supplementation within the past 90 days

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Other
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Double

Number of Arms

4

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Placebo Comparator: Placebo; 30g white rice flour	Dietary supplement: Rice Flour; rice flour powder matched for color, appearance, taste, and solubility
Experimental: Low dose; 5g/day Creatine Monohydrate (25g white rice flour) for 28 days	Dietary supplement: Rice Flour; rice flour powder matched for color, appearance, taste, and solubility; Dietary supplement: Creatine Monohydrate; Creatine monohydrate is a very common supplement used by enthusiasts, athletes, and the general populace
Experimental: Loading dose; Creatine Monohydrate 20g/day (10g white rice flour) for 7 days, followed by maintenance dose of Creatine Monohydrate 5g/day (25g white rice flour) for the remaining 21 days	Dietary supplement: Rice Flour; rice flour powder matched for color, appearance, taste, and solubility; Dietary supplement: Creatine Monohydrate; Creatine monohydrate is a very common supplement used by enthusiasts, athletes, and the general populace
Experimental: High dose; High dose of Creatine Monohydrate 20g/day (10g white rice flour) for the entire 28 day period	Dietary supplement: Rice Flour; rice flour powder matched for color, appearance, taste, and solubility; Dietary supplement: Creatine Monohydrate; Creatine monohydrate is a very common supplement used by enthusiasts, athletes, and the general populace

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Determine the effect of creatine supplementation on anaerobic performance in the PFT by measuring change in repetitions of push-ups and sit-ups.	An initial mock AF PFT will be administered. Individual component raw numbers, scores, and composite scores will be recorded. Participants will self-take their prescribed regimen twice a day, in addition to exercise 5 days/week. Within 7 days of completing the prescribed treatment and exercise course, participants will undergo another mock AF PFT. The individual component raw numbers, scores, and composite scores will be recorded and compared to initial mock scores	28 days
Determine the effect of creatine supplementation on aerobic performance in the PFT by measuring change in 1.5 mile run time.	An initial mock AF PFT will be administered. Individual component raw numbers, scores, and composite scores will be recorded. Participants will self-take their prescribed regimen twice a day, in addition to exercise 5 days/week. Within 7 days of completing the prescribed treatment and exercise course, participants will undergo another mock AF PFT. The individual component raw numbers, scores, and composite scores will be recorded and compared to initial mock scores	28 days
Determine the effect of creatine supplementation on body composition as it relates to the PFT by measuring change in abdominal circumference	An initial mock AF PFT will be administered. Individual component raw numbers, scores, and composite scores will be recorded. Participants will self-take their prescribed regimen twice a day, in addition to exercise 5 days/week. Within 7 days of completing the prescribed treatment and exercise course, participants will undergo another mock AF PFT. The individual component raw numbers, scores, and composite scores will be recorded and compared to initial mock scores	28 days

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Determine how renal function is affected by creatine supplementation by measuring renal function labs (BUN/Creatinine/GFR-with Cys C) before and after the study period.	Labs will be draw before initiation of prescribed treatment. Once the 28-day study period has been completed, each participant will be sent to the DGMC laboratory for a final blood draw	28 days
Assess for possible liver damage resulting from creatine supplementation by measuring liver function labs (AST/ALT/Alk Phos) before and after the study period.	Labs will be draw before initiation of prescribed treatment. Once the 28-day study period has been completed, each participant will be sent to the DGMC laboratory for a final blood draw	28 days
Evaluate the risk of rhabdomyolysis with creatine supplementation by measuring creatine kinase before and after the study period.	Labs will be draw before initiation of prescribed treatment. Once the 28-day study period has been completed, each participant will be sent to the DGMC laboratory for a final blood draw	28 days
Treatment compliance as determined by medication diary.	Participants will be given a log book to record their supplement compliance. They will meet with the study coordinator at the two-week mark (between days 10-14) and review their logbook to ensure they are appropriately taking their supplements. Once the 28-day study period has been completed, each participant with meet with a study team member again to turn in their log book	28 days
Quality of workout as determined by exercise diary.	Participants will be given a log book to record their exercise history. They will meet with the study coordinator at the two-week mark (between days 10-14) and review their logbook to ensure they are meeting the requirement of exercising 4 out of 5 days/week. Once the 28-day study period has been completed, each participant with meet with a study team member again to turn in their log book	28 days

Collaborators and Investigators

• Sponsor: David Grant U.S. Air Force Medical Center
• Investigators: Principal Investigator: Stephen D Kasteler, MD, US Air Force

Study record dates

Study Major Dates

• Study Start (Actual): August 1, 2015
• Primary Completion (Actual): February 13, 2018
• Study Completion (Actual): February 13, 2018

Study Registration Dates

• First Submitted: December 7, 2015
• First Submitted That Met QC Criteria: January 19, 2016
• First Posted (Estimate): January 22, 2016

Study Record Updates

• Last Update Posted (Actual): April 3, 2020
• Last Update Submitted That Met QC Criteria: April 1, 2020
• Last Verified: April 1, 2020

More Information

Terms related to this study

• Keywords: exercise; supplement; fitness; creatine; creatine monohydrate
• Other Study ID Numbers: FDG20150021H

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: No

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No